報價延遲最少15分鐘:2025/09/16 23:15 EDT
常規時段
|
|
|
|
|
||||||||||||
|
|
|
|
|
1.08 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-0.04/0.17
|
|
企業價值
18.04M
|
| 資產負債 |
|
每股賬面淨值
2.36
|
| 現金流量 |
|
現金流量率
0.08
|
| 損益表 |
|
收益
1.76M
|
|
每股收益
6.03
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2025/09/16 23:15 EDT
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories. |
